Literature DB >> 10828502

13-Week oral repeated administration toxicity study of bovine lactoferrin in rats.

K Yamauchi1, T Toida, S Nishimura, E Nagano, O Kusuoka, S Teraguchi, H Hayasawa, S Shimamura, M Tomita.   

Abstract

Bovine lactoferrin (LF), which is an iron-binding glycoprotein in milk, was administered orally to groups of 12 males and 12 female rats at dose levels of 200, 600 and 2000mg/kg/day once daily for 13 weeks and its toxicity on repeated administration was examined. Throughout the administration period, there were no deaths caused by administration of the test compound, nor were there any adverse effects noted in the general condition of the animals. The study findings concerning body weight and food consumption, ophthalmology, urinalysis including water consumption, haematology, blood chemistry, necropsy, organ weights and histopathology revealed that there were no apparent changes due to administration of LF. Therefore, the level of LF at which no adverse effect was observed was considered to be 2000mg/kg/day for both sexes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828502     DOI: 10.1016/s0278-6915(00)00036-3

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  9 in total

1.  Iron bioavailability from supplemented formula milk: effect of lactoferrin addition.

Authors:  Sonia Fernández-Menéndez; María L Fernández-Sánchez; Héctor González-Iglesias; Belén Fernández-Colomer; José López-Sastre; Alfredo Sanz-Medel
Journal:  Eur J Nutr       Date:  2016-10-18       Impact factor: 5.614

2.  Influence of bovine lactoferrin on expression of presentation molecules on BCG-infected bone marrow derived macrophages.

Authors:  Shen-An Hwang; Marian L Kruzel; Jeffrey K Actor
Journal:  Biochimie       Date:  2008-04-27       Impact factor: 4.079

Review 3.  Natural Compounds With Antibacterial Activity Against Cronobacter spp. in Powdered Infant Formula: A Review.

Authors:  Gökçe Polat Yemiş; Pascal Delaquis
Journal:  Front Nutr       Date:  2020-11-23

4.  Safety evaluation of whey derived beta-lactoglobulin, Lacprodan® BLG.

Authors:  Marianne Dybdahl; David Benjamin Selesko; Ulla Ramer Mikkelsen
Journal:  Toxicol Rep       Date:  2021-03-19

5.  Fluid-Phase Endocytosis and Lysosomal Degradation of Bovine Lactoferrin in Lung Cells.

Authors:  Edward John Sayers; Iwan Palmer; Lucy Hope; Paul Hope; Peter Watson; Arwyn Tomos Jones
Journal:  Pharmaceutics       Date:  2022-04-13       Impact factor: 6.525

6.  Bovine lactoferrin ameliorates ferric nitrilotriacetate-induced renal oxidative damage in rats.

Authors:  Yasumasa Okazaki; Isato Kono; Takayoshi Kuriki; Satomi Funahashi; Soichiro Fushimi; Mohammad Iqbal; Shigeru Okada; Shinya Toyokuni
Journal:  J Clin Biochem Nutr       Date:  2012-08-04       Impact factor: 3.114

7.  Histologic and histomorphometric evaluation of the effect of lactoferrin combined with anorganic bovine bone on healing of experimentally induced bony defects on rabbit calvaria.

Authors:  Mojgan Paknejad; Amir Reza Rokn; Ali Akbar Sabur Yaraghi; Flora Elhami; Mohammad Javad Kharazifard; Neda Moslemi
Journal:  Dent Res J (Isfahan)       Date:  2012-12

8.  Protocol for the Lactoferrin Infant Feeding Trial (LIFT): a randomised trial of adding lactoferrin to the feeds of very-low birthweight babies prior to hospital discharge.

Authors:  Andrew Martin; Alpana Ghadge; Paolo Manzoni; Kei Lui; Rebecca Brown; William Tarnow-Mordi
Journal:  BMJ Open       Date:  2018-10-02       Impact factor: 2.692

Review 9.  Lactoferrin's Anti-Cancer Properties: Safety, Selectivity, and Wide Range of Action.

Authors:  Antimo Cutone; Luigi Rosa; Giusi Ianiro; Maria Stefania Lepanto; Maria Carmela Bonaccorsi di Patti; Piera Valenti; Giovanni Musci
Journal:  Biomolecules       Date:  2020-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.